RxDoctor Payments Data

Randolph Pinto, MD

Family Medicine · Louisville, CONPI 1285619411

Payments from drug & device makers

$10,868in general payments, 2019–2025

Across 618 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • AstraZeneca$850
  • Lilly USA, LLC$724
  • GSK$581
  • Antares Pharma, Inc.$528
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$10,832100%
  • Education$360%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)88$1,661
Amgen(2 entities)62$1,078
AstraZeneca47$850
Lilly USA, LLC54$724
GSK33$581
Antares Pharma, Inc.40$528
Pfizer32$481
Bayer28$453
Johnson & Johnson23$396
Esperion Therapeutics, Inc.22$366
Novo Nordisk20$365
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$254
Amarin Pharma, Inc.14$245
Exact Sciences11$245
Otsuka America Pharmaceutical, Inc.14$239
Lundbeck LLC10$219
Novartis7$169
Teva Pharmaceuticals USA, Inc.7$155
Sanofi-aventis U.S. LLC6$144
Corium, LLC6$113
Madrigal Pharmaceuticals1$100
Astellas Pharma US Inc4$90
Abbott4$87
E.r. Squibb & Sons, L.L.C.4$84
Nestle Healthcare Nutrition Inc.4$65
Biohaven Pharmaceutical Holding Company Ltd.3$60
Daiichi Sankyo Inc.3$55
Kaleo, Inc.3$54
Edwards Lifesciences1$53
Sanofi Pasteur Inc.3$49
Halozyme Inc3$48
Alfasigma USA, Inc.2$48
Kowa Pharmaceuticals America, Inc.3$46
Amphastar Pharmaceuticals, Inc.1$45
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$42
Bausch Health US, LLC2$41
Cleerly, Inc.2$38
Biohaven Pharmaceuticals, Inc.2$38
Exeltis, USA Inc.1$35
Dynavax Technologies Corporation2$34
Genentech USA, Inc.2$34
Almatica Pharma LLC2$33
Cranial Technologies, Inc2$33
Boehringer Ingelheim2$32
Mayne Pharma Commercial LLC1$31
Strongbridge US Inc.2$30
Axsome Therapeutics, Inc.1$29
Clarus Therapeutics Inc.2$26
Hologic Sales And Service, LLC1$26
Sumitomo Pharma America, Inc.1$25
Azurity Pharmaceuticals, Inc.1$24
Therapeuticsmd, Inc.2$24
Ironshore Pharmaceuticals Inc.1$22
Eisai Inc.1$18
Shire North American Group Inc1$16
Aimmune Therapeutics, Inc.1$16
Neotract Inc.1$15
Inogen, Inc.1$15
Merck1$14
IBSA Pharma Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,868 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$103,617
Medicare patients
314
Services billed
2,106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide45$63,057
EliquisApixaban52$59,903
XareltoRivaroxaban41$56,598
OzempicSemaglutide41$46,121
FarxigaDapagliflozin Propanediol33$39,101
TrulicityDulaglutide23$26,903
WegovySemaglutide19$26,399
JardianceEmpagliflozin20$25,630
RybelsusSemaglutide17$18,888
Repatha SureclickEvolocumab15$14,273
Rosuvastatin Calcium906$11,041
SymbicortBudesonide/Formoterol Fumarate16$7,955
Ezetimibe207$5,548
BelsomraSuvorexant12$5,419
VyvanseLisdexamfetamine Dimesylate11$4,370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy, Rybelsus$365$91,40877 claims
Lilly USA, LLCMounjaro, Trulicity$724$89,96068 claims
PfizerEliquis, Toviaz$481$63,89164 claims
Johnson & JohnsonXarelto$396$56,59841 claims
AstraZenecaFarxiga, Symbicort$850$47,05649 claims
Boehringer IngelheimJardiance$32$25,63020 claims
MerckBelsomra$14$5,41912 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$155$2,35611 claims
AbbVieSynthroid$1,661$1,97949 claims
Almatica Pharma LLCSertraline Hcl$33$96671 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Louisville

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →